[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342601-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342601-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","flavokawain-c-inhibits-proliferation-and-migration-of-liver-cancer-cells-through-fakpi3kakt-signaling-pathway","Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway","","Study evaluates flavokawain C, a kava-derived natural compound, for potential liver cancer therapy and clarifies its molecular basis. In vivo drug distribution supports preferential enrichment in liver tissues. In vitro assays show flavokawain C suppresses proliferation and migration, promotes apoptosis, and triggers robust DNA damage with corresponding response. Mechanistic analyses using KEGG RNA-seq, molecular dynamics, bioinformatics, and western blot indicate marked inhibition of the FAK/PI3K/AKT pathway via reduced phosphorylation through ATP-site binding. Xenograft models further confirm tumor growth inhibition with minimal adverse effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/flavokawain-c-inhibits-proliferation-and-migration-of-liver-cancer-cells-through-fakpi3kakt-signaling-pathway/342601/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/flavokawain-c-inhibits-proliferation-and-migration-of-liver-cancer-cells-through-fakpi3kakt-signaling-pathway/342601.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on flavokawain C?","Question",{"text":63,"@type":64},"To investigate flavokawain C’s potential applicability and underlying mechanisms in liver cancer treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were flavokawain C’s anti-cancer effects on liver cancer cells evaluated?",{"text":68,"@type":64},"Cell proliferation, apoptosis, and migration effects were assessed using multiple assays, and the anticancer effect was confirmed using a xenograft tumor model.",{"name":70,"@type":61,"acceptedAnswer":71},"Which signaling pathway is inhibited by flavokawain C, and how?",{"text":72,"@type":64},"Flavokawain C suppresses the FAK/PI3K/AKT signaling pathway by reducing phosphorylation of FAK and PI3K, attributed to binding to their ATP sites.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342601,1790788120,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Journal of Cancer Research and Clinical Oncology (2024) 150:117  \n[https://doi.org/10.1007/s00432-024-05639-z](https://doi.org/10.1007/s00432-024-05639-z)  \nFlavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway  \nRongWang1,2 · Rizhao Li2 · Huibing Yang2 · Xuejiao Chen1,2 · Liangliang Wu2 · Xiaohui Zheng2 · Yuepeng Jin1  \nReceived: 4 January 2024 / Accepted: 1 February 2024 / Published online: 9 March 2024 © The Author(s) 2024  \nAbstract  \nPurpose This study investigated the potential applicability and the underlying mechanisms of flavokawain C, a natural compound derived from kava extracts, in liver cancer treatment.  \nMethods Drug distribution experiment used to demonstrate the preferential tissues enrichment of flavokawain C. Cell proliferation, apoptosis and migration effect of flavokawain C were determined by MTT, colony formation, EdU staining, cell adhesion, transwell, flow cytometry and western blot assay. The mechanism was explored by comet assay, immunofluorescence assay, RNA-seq-based Kyoto encyclopedia of genes and genomes analysis, molecular dynamics, bioinformatics analysis and western blot assay. The anticancer effect of flavokawain C was further confirmed by xenograft tumor model. Results The studies first demonstrated the preferential enrichment of flavokawain C within liver tissues in vivo. The findings demonstrated that flavokawain C significantly inhibited proliferation and migration of liver cancer cells, induced cellular apoptosis, and triggered intense DNA damage along with strong DNA damage response. The findings from RNA-seq-based KEGG analysis, molecular dynamics, bioinformatics analysis, and western blot assay mechanistically indicated that treatment with flavokawain C notably suppressed the FAK/PI3K/AKT signaling pathway in liver cancer cells. This effect was attributed to the induction of gene changes and the binding of flavokawain C to the ATP sites of FAK and PI3K, resulting in the inhibition of their phosphorylation. Additionally, flavokawain C also displayed the strong capacity to inhibit Huh- 7-derived xenograft tumor growth in mice with minimal adverse effects.  \nConclusions These findings identified that flavokawain C is a promising anticancer agent for liver cancer treatment.  \nKeywords Flavokawain C · Liver cancer · Proliferation · Migration · FAK/PI3K/AKT pathway · DNA damage  \nAbbreviations  \nROS Reactive oxygen species  \nALT Serum alanine transferase  \nAST Serum aspartate aminotransferase H&E Hematoxylin eosin  \nIHC Immunohistochemical  \nMTT 3-(4,5)-Dimethylthiahiazo  \n(-z-y1)-3,5-di-phenytetrazoliumromide DMSO Dimethyl sulfoxide  \nPI Propidium iodide  \n* Xiaohui Zheng [zhengxh@wmu.edu.cn](zhengxh@wmu.edu.cn)  \n* Yuepeng Jin [jinyuepeng@wzhospital.cn](jinyuepeng@wzhospital.cn)  \n1 National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China  \n2 Wenzhou Medical University, Wenzhou 325000, China  \nIF Immunofluorescence  \nTCGA The Cancer Genome Atlas FAK Focal adhesion kinase PI3K Phosphoinositide 3-kinase  \nIntroduction  \nLiver cancer stands as a prevailing global malignancy, marked by escalating morbidity and mortality annually (Llovet et al. 2021 ; Mcglynn et al. 2021) . The nonspecific nature of early liver cancer symptoms, coupled with the absence of effective early screening methods, contributes to delayed-stage diagnosis, thereby engendering treatment complexities. Furthermore, the high metabolic rate and the swift drug clearance, along with drug resistance and drug-induced liver damage, curtailed the effectiveness of conventional treatment modalities, including surgery, chemotherapy, and radiotherapy (Anwanwan et al.  \n2020 ; Sperandio et al. 2022) . Furthermore, the intricate interplay of liver cancer's heterogeneity, complexity, and immune tolerance undermines the feasibility of achieving clinical expectations through targeted therapy and immunotherapy","cbCaivUmhUK3Of7j","https://ap.wps.com/l/cbCaivUmhUK3Of7j","pdf",19456894,17,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main purpose of the study on flavokawain C?\",\"answer\":\"To investigate flavokawain C’s potential applicability and underlying mechanisms in liver cancer treatment.\"},{\"question\":\"How were flavokawain C’s anti-cancer effects on liver cancer cells evaluated?\",\"answer\":\"Cell proliferation, apoptosis, and migration effects were assessed using multiple assays, and the anticancer effect was confirmed using a xenograft tumor model.\"},{\"question\":\"Which signaling pathway is inhibited by flavokawain C, and how?\",\"answer\":\"Flavokawain C suppresses the FAK/PI3K/AKT signaling pathway by reducing phosphorylation of FAK and PI3K, attributed to binding to their ATP sites.\"}]","Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway | PDF",1790047345,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e571e9df08e30b9244897618c6221cd7.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/faa3f6e8d4b0e1e01d03402933671d77.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3f655460f85f66cadb9efe578c023f8.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eecc7ebdb7ea0a8d8f39d8d3667c5a6.webp",980,1301]